Wilate powder and solvent for solution for injection
*Company:
Octapharma LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 16 February 2023
File name
20221214_spc_18x_500-1000_IE_16.15_en.pdf
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 09 February 2023
File name
Wilate IE SPC 20201202.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 08 April 2021
File name
Wilate IE PIL 20201202.pdf
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
Updated on 08 April 2021
File name
Wilate IE SPC 20201202.pdf
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 30 April 2020
File name
Wilate IE PIL - 20200128 - Apr 2020.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 30 April 2020
File name
Wilate IE SPC - 20200415 - Apr 2020.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 20 December 2019
File name
Wilate IE PIL - 20190522 - Dec 2019.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to information for healthcare professionals
Updated on 20 December 2019
File name
Wilate IE SPC - 20191219 - Dec 2019.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 6.6 - Special precautions for disposal and other handling
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 15 August 2018
File name
Wilate IE SPC - June 2018.pdf
Reasons for updating
- File format updated to PDF
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 26 June 2018
File name
Wilate IE SPC - June 2018.docx
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 26 June 2018
File name
Wilate IE PIL - June 2018.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
- Change to further information section
Updated on 02 March 2016
File name
PIL_16653_535.pdf
Reasons for updating
- New PIL for new product
Updated on 13 July 2015
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 13 July 2015
Reasons for updating
- Change to section 6.4 - Special precautions for storage
- Change to section 9 - Date of renewal of authorisation
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 21 April 2015
Reasons for updating
- New SPC for medicines.ie
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Octapharma Ltd
Address:
MAH: Octapharma (IP) SPRL, Allée de la Recherche 65, 1070 Anderlecht, Belgium, (Local Agent: Octapharma Ltd, Glassworks House, 32 Shudehill, Manchester, Lancashire, M4 1EZ)Medical Information E-mail:
medinfo.uk@octapharma.comTelephone:
+44 (0)161 837 3770Website:
https://www.octapharma.co.uk